Huntsman Corporation 2025 Q1 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2025, for Huntsman Corporation and its wholly-owned subsidiary, Huntsman International LLC. Huntsman is a global manufacturer of diversified organic chemical products operating in three segments: Polyurethanes, Performance Products, and Advanced Materials. The filing includes unaudited condensed consolidated financial statements for both entities.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Total Revenues | $1,410 million | $1,470 million |
| Gross Profit | $201 million | $201 million |
| Operating Income | $42 million | ($38 million) |
| Net Income (Loss) | $11 million | ($23 million) |
| Net Loss Attributable to Huntsman Corp | ($5 million) | ($37 million) |
| Adjusted EBITDA | $72 million | $81 million |
| Free Cash Flow | ($107 million) | ($105 million) |
| Cash and Cash Equivalents | $334 million | $552 million |
| Total Debt | $1,954 million | $1,835 million |
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased 4% ($60 million) year-over-year, driven by lower sales volumes in Performance Products and lower average selling prices in Polyurethanes and Advanced Materials.
- Profitability Improvement: Operating income improved from a loss of $38 million in Q1 2024 to a profit of $42 million in Q1 2025. This turnaround was primarily due to a $33 million net income from a litigation settlement (Praxair/Linde) and a significant reduction in restructuring costs ($1 million vs. $11 million in the prior year).
- One-Time Items: Q1 2024 included a $71 million prepaid asset write-off and a $52 million gain on asset acquisition (SLIC), whereas Q1 2025 included a $5 million gain on asset acquisition and the aforementioned litigation income.
- Segment Performance:
- Polyurethanes: Adjusted EBITDA increased 8% to $42 million due to lower raw material costs and higher volumes, despite lower selling prices.
- Performance Products: Adjusted EBITDA decreased 29% to $30 million due to lower sales volumes caused by customer demand and unplanned outages in Germany.
- Advanced Materials: Adjusted EBITDA decreased 16% to $36 million due to lower average selling prices.
- Debt Management: The company satisfied and discharged its 4.25% Senior Notes due April 2025 (approx. $315 million) in March 2025. Concurrently, net borrowings on revolving facilities increased by $427 million.
Guidance, Outlook, and Risks
- Capital Expenditures: Management expects to spend between $180 million and $190 million on capital expenditures for the full year 2025, funded by cash from operations.
- Restructuring: The company expects to record further restructuring expenses of approximately $14 million through 2027 related to the Polyurethanes segment and $7 million through 2027 for the Advanced Materials segment.
- Liquidity: As of March 31, 2025, the company had $1,294 million in combined cash and unused borrowing capacity ($334 million cash, $924 million revolver availability, $36 million A/R program availability).
- Share Repurchases: No shares were repurchased under the $2 billion program during Q1 2025. Approximately $547 million remains authorized.
- Risks: Key risks include foreign currency exchange rate fluctuations, commodity price volatility, and the impact of valuation allowances on income tax expenses in certain jurisdictions. The company noted that effective tax rates are significantly affected by the mix of income and losses across jurisdictions.
Investor Verification Checklist
- Litigation Proceeds: Verify the timing of cash receipt for the $66 million Praxair/Linde award (recognized as $33 million net income) and the expected $8 million future tax liability.
- Inventory Build: Investigate the $113 million increase in inventory, attributed to higher costs and volumes, to assess potential working capital strain or demand forecasting issues.
- Debt Covenant Compliance: Confirm compliance with the amended leverage ratio covenant in the 2022 Revolving Credit Facility, which was amended in February 2025 to allow higher ratios through Q4 2025.
- Non-GAAP Reconciliations: Review the reconciliation of Net Loss to Adjusted EBITDA and Adjusted Net Loss to understand the impact of the $33 million litigation income and $9 million valuation allowance establishment on reported metrics.
- Foreign Currency Impact: Assess the sensitivity of future earnings to foreign currency translation, which contributed to revenue declines in the Polyurethanes and Advanced Materials segments.